Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localized high concentration of nitric oxide in the body.
Type:
Grant
Filed:
March 9, 2001
Date of Patent:
July 9, 2002
Assignee:
AnorMED Inc.
Inventors:
Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
Abstract: New pharmaceutical compositions and pharmaceutical compositions comprising metal complexes have activity against diseases caused by or related to overproduction or localised high concentration of nitric oxide in the body.
Type:
Grant
Filed:
October 19, 1998
Date of Patent:
September 4, 2001
Assignee:
AnorMED Inc.
Inventors:
Michael J Abrams, Simon P Fricker, Barry A Murrer, Owen J Vaughan
Abstract: A pharmaceutical composition containing a non-specific (NS) suppressor cell inducing compound and cyclosporin A and a pharmaceutically acceptable carrier or diluent, and method of inducing an immunosuppressive effect in a mammal, including a hyman, in need thereof which comprises administering an effective dose of a non-specific suppressor cell inducing compound and cyclosporin A to such mammal.
Abstract: Invented is a method of treatment of psoriasis in a mammal in need thereof which comprises administering to such mammal an effective amount of a substituted azaspirane.
Abstract: The present invention is directed to an improved antihyperlipidemic agent, the dimaleate salt of 2-?2-(dimethylamino)ethyl!-8,8-dipropyl-2-azaspiro?4.5!decane.
Abstract: Invented are methods of inhibiting the production of cytokines, particularly inhibiting the production of interleukin-1 and inhibiting the production of tumor necrosis factor in a mammal in need thereof which comprises administering to such mammal an effective amount of an azaspirane derivative.
Type:
Grant
Filed:
January 7, 1997
Date of Patent:
May 4, 1999
Assignee:
AnorMED, Inc.
Inventors:
Alison Mary Badger, Wanda Bernadette High